XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Incentive Plan (Tables)
9 Months Ended
Sep. 30, 2021
Schedule of Additional Information on Stock Option Grants And Vesting

The following table summarizes additional information on stock option grants and vesting (in thousands):

 

 

 

2019 Plan

 

 

 

Nine Months Ended September 30, 2021

 

 

Nine Months Ended September 30, 2020

 

Total fair value of stock options granted

 

$

2,293

 

 

$

9,241

 

Total fair value of options vested

 

 

369

 

 

 

-

 

Schedule of Black Scholes model for the Private Warrants

To estimate the fair value of the Private Warrants as of December 31, 2020 and September 30, 2021, the Company used a Black Scholes closed form model, which is a Level 3 fair value measurement. Significant inputs used in the Black Scholes model for the Private Warrants were as follows:

 

 

 

December 31, 2020

& September 30, 2021

 

 

 

 

 

 

Expected volatility

 

 

16.00

%

Expected term (in years)

 

 

3.97

 

Risk free interest rate

 

 

1.74

%

Dividend yield

 

 

0.00

%

Exercise Price

 

$

11.50

 

Fair value of Common Stock

 

$

8.05

 

The following table summarizes the assumptions used in the valuation models to determine the fair value of stock options granted to employees and non-employee directors:

 

 

Nine Months Ended September 30, 2021

 

 

Nine Months Ended September 30, 2020

 

Expected volatility

 

44.06% - 44.61%

 

 

37.63% - 41.24%

 

Expected term (in years)

 

6.0

 

 

6.0

 

Dividend yield

 

0.00%

 

 

0.00%

 

Risk-free interest rate

 

0.70% - 1.00%

 

 

1.43% - 0.30%

 

 

Stock Based Compensation Expense Included In Condensed Consolidated Statements of Comprehensive Loss

Stock-based compensation expense is included in the Company’s Condensed Consolidated Statements of Comprehensive Loss within the following line items (in thousands):

 

 

 

Three Months Ended September 30, 2021

 

 

Three Months Ended September 30, 2020

 

 

Nine Months Ended September 30, 2021

 

 

Nine Months Ended September 30, 2020

 

Cost of revenues

 

$

340

 

 

$

339

 

 

$

1,030

 

 

$

1,020

 

General and administrative

 

 

394

 

 

 

350

 

 

 

1,200

 

 

 

841

 

Research and development

 

 

73

 

 

 

65

 

 

 

209

 

 

 

205

 

Sales and marketing

 

 

195

 

 

 

159

 

 

 

559

 

 

 

486

 

Total

 

$

1,002

 

 

$

913

 

 

$

2,998

 

 

$

2,552

 

Restricted Stock Units [Member]  
Schedule of RSUs Activity Under 2019 Plan

The following table summarizes the Company’s RSU activity:

 

Description

 

RSUs

Outstanding

 

Balance at December 31, 2020

 

 

1,290,432

 

Granted

 

 

434,538

 

Vested

 

 

(103,622

)

Forfeited

 

 

(97,835

)

Expired

 

 

-

 

Balance at September 30, 2021

 

 

1,523,513

 

2019 Plan [Member]  
Schedule of Stock Option Activity Under 2019 Plan

The following table summarizes the Company’s stock option activity under the 2019 Plan:

 

Description

 

Options

Outstanding

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Term (Years)

 

 

Aggregate

Intrinsic

Value (1)

 

Options Outstanding, December 31, 2020

 

 

4,260,753

 

 

$

8.46

 

 

 

9.0

 

 

$

54

 

Granted

 

 

1,277,771

 

 

 

8.03

 

 

 

 

 

 

 

 

 

Exercised

 

 

(4,676

)

 

 

8.00

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(350,928

)

 

 

8.27

 

 

 

 

 

 

 

 

 

Expired

 

 

(56,517

)

 

 

8.12

 

 

 

 

 

 

 

 

 

Options Outstanding, September 30, 2021

 

 

5,126,403

 

 

$

8.37

 

 

 

8.6

 

 

$

5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Vested and Exercisable, September 30, 2021

 

 

1,352,295

 

 

$

8.46

 

 

 

8.3

 

 

$

-

 

Options Vested and Expected to Vest, September 30, 2021

 

 

5,126,403

 

 

$

8.37

 

 

 

8.6

 

 

$

5

 

 

(1)

Aggregate intrinsic value represents the difference between the estimated fair value of the underlying Common Stock and the exercise price of outstanding in-the-money options.